HW&C

HC Wainwright & Co. Latest Price Targets & Analyst Ratings

Stock Analyst Price Price Target Upside
Downside
Rating Date
FN icon
401
Fabrinet
FN
$13.2B
MC
Matthew Caufield
$370.03 $28
92%
downside
Buy 2 years ago
POET icon
402
POET Technologies
POET
$479M
KD
Kevin Dede
$5.28 $5
5%
downside
Buy 2 years ago
LCTX icon
403
Lineage Cell Therapeutics
LCTX
$279M
$1.22 $7
474%
upside
Buy 2 years ago
HIVE
404
HIVE Digital Technologies
HIVE
$611M
KD
Kevin Dede
$2.66 $5
88%
upside
Buy 2 years ago
ALLO icon
405
Allogene Therapeutics
ALLO
$255M
DC
Debjit Chattopadhyay
$1.15 $29
2,422%
upside
Buy 2 years ago
BNTC icon
406
Benitec Biopharma
BNTC
$365M
PT
Patrick Trucchio
$13.91 $68
389%
upside
Buy 3 years ago
ANAB icon
407
AnaptysBio
ANAB
$613M
GS
Gobind Singh
$21.90 $35
60%
upside
Buy 3 years ago
CLDX icon
408
Celldex Therapeutics
CLDX
$1.52B
JH
Joseph Hafling
$22.87 $73
219%
upside
Buy 3 years ago
TYRA icon
409
Tyra Biosciences
TYRA
$674M
RS
Raghuram Selvaraju
$12.65 $12
5%
downside
Buy 3 years ago
FRO icon
410
Frontline
FRO
$4.93B
MF
Magnus Fyhr
$22.15 $10
55%
downside
Neutral 3 years ago
HUT
411
Hut 8
HUT
$2.68B
KD
Kevin Dede
$25.38 $25
2%
downside
Buy 3 years ago
TRMD icon
412
TORM
TRMD
$2.25B
MF
Magnus Fyhr
$23.02 $16
31%
downside
Buy 3 years ago
AMRN
413
Amarin Corp
AMRN
$317M
AF
Andrew Fein
$15.33 $60
291%
upside
Neutral 3 years ago
STNG icon
414
Scorpio Tankers
STNG
$2.71B
MF
Magnus Fyhr
$53.05 $38
28%
downside
Buy 3 years ago
ALDX icon
415
Aldeyra Therapeutics
ALDX
$334M
AF
Andrew Fein
$5.56 $15
170%
upside
Buy 3 years ago
ASC icon
416
Ardmore Shipping
ASC
$490M
MF
Magnus Fyhr
$12.04 $8.50
29%
downside
Buy 3 years ago
XRAY icon
417
Dentsply Sirona
XRAY
$2.92B
YC
Yi Chen
$14.62 $48
228%
upside
Neutral 3 years ago
SRRK icon
418
Scholar Rock
SRRK
$3.02B
MK
Michael King
$31.41 $24
24%
downside
Buy 3 years ago
ANAB icon
419
AnaptysBio
ANAB
$613M
MK
Michael King
$21.90 $46
110%
upside
Buy 3 years ago
AGIO icon
420
Agios Pharmaceuticals
AGIO
$2.09B
MK
Michael King
$36.01 $96
167%
upside
Buy 3 years ago
XNCR icon
421
Xencor
XNCR
$610M
MK
Michael King
$8.55 $55
543%
upside
Buy 3 years ago
EXEL icon
422
Exelixis
EXEL
$10.2B
MK
Michael King
$37.88 $42
11%
upside
Buy 3 years ago
CTMX icon
423
CytomX Therapeutics
CTMX
$376M
RB
Robert Burns
$2.28 $11
382%
upside
Buy 3 years ago
COGT icon
424
Cogent Biosciences
COGT
$1.82B
MK
Michael King
$13.05 $31
138%
upside
Buy 3 years ago
NTLA icon
425
Intellia Therapeutics
NTLA
$1.29B
MK
Michael King
$12.06 $182
1,409%
upside
Buy 3 years ago